Drug profile · INN
degarelix acetate
FIRMAGON
degarelix acetate (FIRMAGON) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — degarelix acetate
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
degarelix acetate (FIRMAGON) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor antagonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is degarelix acetate?
degarelix acetate (FIRMAGON) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for degarelix acetate?
FIRMAGON is a marketed brand name for degarelix acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of degarelix acetate?
degarelix acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.